Associations between different measurements of sarcopenic obesity and health outcomes among non-frail community-dwelling older adults in Taiwan
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
The most important issue for the clinical application of sarcopenic obesity (SO) is the lack of a consensus definition. The aim of the present study was to determine the best measurement for SO by estimating the association between various definitions and the risk of falls and metabolic syndrome (MS). We studied a community of 765 adults aged 65 years and older in 2015–2017. Sarcopenia obesity was measured by sarcopenia (defined by low muscle mass with either low handgrip strength or low gait speed or both) plus obesity (defined by waist circumference, body fat percentage and BMI). The MS was defined according to the National Cholesterol Education Program ATP III. Logistic regression models were constructed to examine the relationships between sarcopenia obesity and risk of fall and MS. In the analysis of the fall risk with SO defined by waist circumference, the participants with non-sarcopenia/non-obesity were treated as the reference group. The OR to fall in participants with SO was 10·16 (95 % CI 2·71, 38·13) after adjusting for confounding covariates. In the analysis of the risk of the MS between participants with individual components of sarcopenia coupled with obesity defined by waist circumference, the risk was statistically significant for low gait speed (OR: 7·19; 95 % CI 3·61, 14·30) and low grip strength (OR: 9·19; 95 % CI 5·00, 16·91). A combination of low grip strength and abdominal obesity for identifying SO may be a more precise and practical method for predicting target populations with unfavourable health risks, such as falls risk and MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sarcopenic obesity has been so far identified through various definitions and diagnostic constructs, but it has been consistently demonstrated to be a strong and independent risk factor for frailty, comorbidities and mortality in various highly prevalent disease conditions, as well as for mortality in the general and especially in the older population [17-19].”
From Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement (2022) · cites this paper as [17]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601 · cited 1×
“Sarcopenia was defined as low skeletal muscle mass index with either lowhandgrip strength or low gait speed or both, according to the consensus of the EuropeanWorking Group on Sarcopenia in Older People (EWGSOP) in 2010(21) The cut-off values of low skeletal muscle mass index, low handgrip strength and low gait speed…”
MethodSarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051 · cited 4×
“Based on the sarcopenia definition by AWGS in 2014, the cut-off value for low handgrip strength was less than 26 kg for men and less than 18 kg for women, and a gait speed less than 0·8 m/s was used as the cut-off for low gait speed(14).”
BackgroundMethodInfluentialJanssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139 · cited 2×
“MS was defined as the fulfilment of three or more of the following conditions:(1) hypertension with systolic blood pressure≥ 130 mmHg or diastolic blood pressure≥ 85 mmHg; (2) hyperglycemia with fasting glucose≥ 100 mg/dl;(3) hypertriacylglycerolaemia with serum TAG≥ 150 mg/dl;(4) low level of HDL cholesterol as< 40 m…”
BackgroundSarcopenia: origins and clinical relevance
Rosenberg, I. H. (1997) · The Journal of Nutrition · doi:10.1093/jn/127.5.990s · Cited by 2,399 · cited 2×
“MS was defined as the fulfilment of three or more of the following conditions:(1) hypertension with systolic blood pressure≥ 130 mmHg or diastolic blood pressure≥ 85 mmHg; (2) hyperglycemia with fasting glucose≥ 100 mg/dl;(3) hypertriacylglycerolaemia with serum TAG≥ 150 mg/dl;(4) low level of HDL cholesterol as< 40 m…”
BackgroundOverweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
Adams, K. F., Schatzkin, A., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R., Hollenbeck, A., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,116
The obesity transition: stages of the global epidemic
Jaacks, L. M., Vandevijvere, S., Pan, A., McGowan, C. J., Wallace, C., Imamura, F., Mozaffarian, D., Swinburn, B., & Ezzati, M. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30026-9 · Cited by 1,193
Sarcopenia: alternative definitions and associations with lower extremity function
Newman, A. B., Kupelian, V., Visser, M., Simonsick, E., Goodpaster, B., Nevitt, M., Kritchevsky, S. B., Tylavsky, F. A., Rubin, S. M., Harris, T. B., et al. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2003.51534.x · Cited by 981
Research works printed but not linked: 1
- Qu NN & Li KJ (2004) Study on the reliability and validity of international physical activity questionnaire (Chinese Version, IPAQ). Zhonghua Liu Xing Bing Xue Za Zhi 25, 265-268.
Cited by
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Obesity Facts · doi:10.1159/000521241 · Cited by 1,019
Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO consensus statement
Donini, L. M., Busetto, L., Bischoff, S. C., Cederholm, T., Ballesteros-Pomar, M. D., Batsis, J. A., Bauer, J. M., Boirie, Y., Cruz-Jentoft, A. J., Dicker, D., et al. (2022) · Clinical Nutrition · doi:10.1016/j.clnu.2021.11.014 · Cited by 566
“…and diagnostic constructs, but it has been consistently demonstrated to be a strong and independent risk factor for frailty, comorbidities and mortality in various highly prevalent disease conditions, as well as for mortality in the general and especially in the older population [17–19].”
Phase angle is associated with sarcopenic obesity in post-stroke patients
Yoshimura, Y., Wakabayashi, H., Nagano, F., Matsumoto, A., Shimazu, S., Shiraishi, A., Kido, Y., Bise, T., Hori, K., & Yoneda, K. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.08.018 · Cited by 45
Yoshimura, Y., Wakabayashi, H., Nagano, F., Matsumoto, A., Shimazu, S., Shiraishi, A., Kido, Y., & Bise, T. (2022) · Nutrients · doi:10.3390/nu14194205 · Cited by 38
Sabatino, A., Avesani, C. M., Regolisti, G., Adinolfi, M., Benigno, G. D., Delsante, M., Fiaccadori, E., & Gandolfini, I. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.06.032 · Cited by 42
Metadata
- Authors
- Peng, T.-C., Chen, W.-L., Chen, Y.-Y., Chao, Y.-P., Wu, L.-W., & Kao, T.-W.
- Affiliations
- Tri-Service General Hospital (TW)
- Corresponding author
- Kao, Tung-Wei
- Venue
- British Journal of Nutrition
- Publisher
- Cambridge University Press (CUP)
- Published
- 2021-04-14
- Volume
- 126
- Issue
- 11
- Pages
- 1749-1757
- ISSN
- 0007-1145 (ISSN-L)
- 1475-2662
- OpenAlex
- W3154979295
- Cited by
- 35
- References
- 34
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 16 · 2023: 7 · 2022: 3
- FWCI
- 4.24
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal Of Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
- Health Sciences › Medicine › Physiology (medical) › Body Composition Measurement Techniques
- Keywords
- sarcopenic obesity, sarcopenia, obesity, fall risk, metabolic syndrome, grip strength, walking speed, waist circumference, abdominal obesity, older adults, community-dwelling, health risk prediction
- MeSH terms
- Aged, Humans, Obesity, Taiwan, Outcome Assessment, Health Care, Hand Strength, Sarcopenia, Independent Living
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Associations between different measurements of sarcopenic obesity and health outcomes among non-frail community-dwelling older adults in Taiwan. https://app.cochat.ai/papers/10.1017/s0007114521001288
- The paper
- Peng, T.-C., Chen, W.-L., Chen, Y.-Y., Chao, Y.-P., Wu, L.-W., & Kao, T.-W. (2021). Associations between different measurements of sarcopenic obesity and health outcomes among non-frail community-dwelling older adults in Taiwan. British Journal of Nutrition. https://doi.org/10.1017/s0007114521001288
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.